TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
CCCC

C4 Therapeutics Inc

Healthcare · Biotechnology

3.30$ -2.7% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CCCC
Line item 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
84.3% 81.8% 95.2% 64.3% 66.7% 72.0% 73.7% 71.9%
24.8% 76.6% 45.4% 15.0% 6.9% 33.6% 15.9% 20.8%
24.8% 76.6% 92.9% 61.0% 64.1% 67.4% 70.1% 69.2%
59.0% 3.9% 1.1% 1.1% 0.3% 3.1% 0.9% 0.7%
0.0% 0.0% -14.1%
13.9% 16.0% 4.1% 0.6% 1.7%
154.4% 194.7% 29.8% 23.1% 32.9% 34.6% 38.2% 28.5%
16.3% 28.4% 11.0% 10.1% 10.3% 11.4% 12.9% 9.2%
0.5% 0.7% 0.3% 0.3% 1.6% 1.4% 1.7% 1.8%
0.8% 4.6% 1.4% 0.9% 0.3% 0.4% 0.4% 0.2%
2.5% 2.1% 2.1%
-54.4% -94.7% 70.2% 76.9% 67.1% 65.4% 61.8% 71.5%
-56.9% -99.3% -45.9% -52.8% -91.9% -140.4% -181.3% -205.7%
28.7% 36.3% 10.8% 9.1% 11.3% 13.2% 19.8% 23.1%

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?